Literature DB >> 21533844

Explicit reformulations of the Lambert W-omega function for calculations of the solutions to one-compartment pharmacokinetic models with Michaelis-Menten elimination kinetics.

Marko Goličnik1.   

Abstract

The exact closed-form solutions to the integrated rate equations for one-compartment pharmacokinetic models that obey Michaelis-Menten elimination kinetics were derived recently (Tang and Xiao in J Pharmacokin Pharmacodyn 34:807-827, 2007). These solutions are expressed in terms of the Lambert W(x)-omega function; however, unfortunately, most of the available computer programs are not set up to handle equations that involve the W(x) function. Therefore, in this article, I provide alternative explicit analytical equations expressed in terms of elementary mathematical functions that accurately approximate exact solutions and can be simply calculated using any optional standard software.

Mesh:

Year:  2011        PMID: 21533844     DOI: 10.1007/s13318-011-0040-2

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Explicit reformulations of time-dependent solution for a Michaelis-Menten enzyme reaction model.

Authors:  Marko Golicnik
Journal:  Anal Biochem       Date:  2010-07-01       Impact factor: 3.365

Review 2.  Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.

Authors:  Goonaseelan Colin Pillai; France Mentré; Jean-Louis Steimer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

3.  Progress curve analysis for enzyme and microbial kinetic reactions using explicit solutions based on the Lambert W function.

Authors:  Chetan T Goudar; Steve K Harris; Michael J McInerney; Joseph M Suflita
Journal:  J Microbiol Methods       Date:  2004-12       Impact factor: 2.363

Review 4.  The virtual laboratory approach to pharmacokinetics: design principles and concepts.

Authors:  Wilhelm Huisinga; Regina Telgmann; Michael Wulkow
Journal:  Drug Discov Today       Date:  2006-09       Impact factor: 7.851

5.  Challenges and opportunities with modelling and simulation in drug discovery and drug development.

Authors:  T Lavé; N Parrott; H P Grimm; A Fleury; M Reddy
Journal:  Xenobiotica       Date:  2007 Oct-Nov       Impact factor: 1.908

6.  Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution.

Authors:  Max von Kleist; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-09-25       Impact factor: 2.745

7.  Explicit solution of integrated 1 - exp equation for predicting accumulation and decline of concentrations for drugs obeying nonlinear saturation kinetics.

Authors:  Frieder Keller; Bertram Hartmann; David Czock
Journal:  Ther Drug Monit       Date:  2009-12       Impact factor: 3.681

8.  The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.

Authors:  D S Burgess; C R Frei; J S Lewis Ii; K R Fiebelkorn; J H Jorgensen
Journal:  Clin Microbiol Infect       Date:  2007-01       Impact factor: 8.067

9.  The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.

Authors:  Phylinda L S Chan; Philippe Jacqmin; Marc Lavielle; Lynn McFadyen; Barry Weatherley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-19       Impact factor: 2.745

10.  One-compartment model with Michaelis-Menten elimination kinetics and therapeutic window: an analytical approach.

Authors:  Sanyi Tang; Yanni Xiao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-09-15       Impact factor: 2.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.